ORG Wealth Partners LLC purchased a new stake in MetLife, Inc. (NYSE:MET – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 911 shares of the financial services provider’s stock, valued at approximately $75,000.
Several other large investors have also modified their holdings of the business. Ashton Thomas Private Wealth LLC purchased a new stake in MetLife in the 2nd quarter valued at approximately $126,000. American Century Companies Inc. raised its holdings in shares of MetLife by 16.7% in the second quarter. American Century Companies Inc. now owns 1,028,848 shares of the financial services provider’s stock worth $72,215,000 after acquiring an additional 146,940 shares during the last quarter. Forsta AP Fonden lifted its position in shares of MetLife by 23.1% in the second quarter. Forsta AP Fonden now owns 179,900 shares of the financial services provider’s stock valued at $12,627,000 after acquiring an additional 33,800 shares in the last quarter. BOKF NA boosted its stake in shares of MetLife by 117.8% during the second quarter. BOKF NA now owns 7,389 shares of the financial services provider’s stock valued at $519,000 after acquiring an additional 3,997 shares during the last quarter. Finally, Oppenheimer & Co. Inc. raised its stake in MetLife by 3.4% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 28,616 shares of the financial services provider’s stock valued at $2,009,000 after purchasing an additional 954 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.
MetLife Trading Down 3.0 %
NYSE MET opened at $80.30 on Friday. The firm has a market capitalization of $55.60 billion, a price-to-earnings ratio of 16.19, a PEG ratio of 0.76 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a one year low of $64.61 and a one year high of $89.05. The company’s 50 day moving average price is $82.97 and its 200 day moving average price is $78.92.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the stock. TD Cowen raised their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Barclays lifted their target price on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, January 6th. Wells Fargo & Company increased their price target on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, JPMorgan Chase & Co. increased their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $90.00.
Get Our Latest Stock Analysis on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- 5 Top Rated Dividend Stocks to Consider
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- The 3 Best Blue-Chip Stocks to Buy Now
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.